Repaglinide and Proscar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repaglinide (repaglinide) and Proscar (finasteride). Common drug interactions include confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Repaglinide and Proscar. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Proscar?

Proscar has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 13,379 Proscar users. Check the latest studies of Proscar.



On Jul, 15, 2026

16 people who take Repaglinide and Proscar together, and have interactions are studied.

Repaglinide and Proscar drug interactions.

What are the common drug interactions of Repaglinide and Proscar, by gender? *:

female:

n/a

male:

  1. Confusional state
  2. Anaemia (lack of blood)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Transfusion reaction (a serious problem that occurs after a patient receives a transfusion of blood)
  5. Erysipelas (bacterial skin infection)
  6. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  7. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  8. Fall
  9. Oedema peripheral (superficial swelling)
  10. Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)

What are the common drug interactions of Repaglinide and Proscar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Confusional state
  2. Anaemia (lack of blood)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Transfusion reaction (a serious problem that occurs after a patient receives a transfusion of blood)
  5. Erysipelas (bacterial skin infection)
  6. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  7. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  8. Fall
  9. Oedema peripheral (superficial swelling)
  10. Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 8 people, 50.00%
  2. Stable Angina (a constant chest pain): 8 people, 50.00%
  3. Pancreatic Carcinoma (pancreatic cancer): 8 people, 50.00%
  4. Pain: 8 people, 50.00%
  5. Infection: 8 people, 50.00%
  6. Hypokalemia (low potassium): 8 people, 50.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 50.00%
  8. Constipation: 8 people, 50.00%
  9. Type 2 Diabetes: 6 people, 37.50%
  10. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and Proscar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Repaglinide and Proscar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proscar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repaglinide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proscar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on repaglinide and finasteride (the active ingredients of Repaglinide and Proscar, respectively), and Repaglinide and Proscar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: